|
 | Up a level |
Thakur, C and Tripathi, A and Ravichandran, S and Shivananjaiah, A and Chakraborty, A and Varadappa, S and Chikkavenkatappa, N and Nagarajan, D and Lakshminarasimhaiah, S and Singh, A and Chandra, N (2022) A new blood-based RNA signature (R9), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort. In: iScience, 25 (2).
Jameei, A and Nagarajan, D and Sarikhani, M and Chandra, N and Karande, AA (2019) Development and Characterization of a Potent Tumor Necrosis Factor-Alpha-Blocking Agent. In: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 38 (4). pp. 145-156.
Nagarajan, D and Nagarajan, T and Nanajkar, N and Chandra, N (2019) A uniform in vitro efficacy dataset to guide antimicrobial peptide design. In: Data, 4 (1).
